Formulations:
- Parenteral > General injections > IV: 10 mg per mL in 1 mL vial; 10 mg per mL in 5 mL vial
Parenteral > General injections > IV: 10 mg per mL in 1 mL vial; 10 mg per mL in 5 mL vial
Oral > Solid > capsule: 20 mg; 30 mg; 80 mg
Indications:
- Other specified malignant neoplasms of bronchus or lung
- Other specified malignant neoplasms of breast
- Rhabdomyosarcoma primary site
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Formulations:
- Parenteral > General injections > IV: 10 mg per mL in 1 mL vial; 10 mg per mL in 5 mL vial
Parenteral > General injections > IV: 10 mg per mL in 1 mL vial; 10 mg per mL in 5 mL vial
Oral > Solid > capsule: 20 mg; 30 mg; 80 mg
Indications:
- Other specified malignant neoplasms of bronchus or lung
- Other specified malignant neoplasms of breast
- Rhabdomyosarcoma primary site
Source: EML workbook import